NO20023866L - Farmasöytisk preparat - Google Patents

Farmasöytisk preparat

Info

Publication number
NO20023866L
NO20023866L NO20023866A NO20023866A NO20023866L NO 20023866 L NO20023866 L NO 20023866L NO 20023866 A NO20023866 A NO 20023866A NO 20023866 A NO20023866 A NO 20023866A NO 20023866 L NO20023866 L NO 20023866L
Authority
NO
Norway
Prior art keywords
membrane
nail
forming
solvent
solution
Prior art date
Application number
NO20023866A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023866D0 (no
Inventor
Robert J Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of NO20023866D0 publication Critical patent/NO20023866D0/no
Publication of NO20023866L publication Critical patent/NO20023866L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20023866A 2000-02-16 2002-08-15 Farmasöytisk preparat NO20023866L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO20023866D0 NO20023866D0 (no) 2002-08-15
NO20023866L true NO20023866L (no) 2002-10-01

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023866A NO20023866L (no) 2000-02-16 2002-08-15 Farmasöytisk preparat

Country Status (17)

Country Link
EP (1) EP1257248B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005503318A (cg-RX-API-DMAC7.html)
KR (2) KR20030016227A (cg-RX-API-DMAC7.html)
CN (1) CN1422142A (cg-RX-API-DMAC7.html)
AT (1) ATE526917T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001243189B2 (cg-RX-API-DMAC7.html)
BR (1) BR0108438A (cg-RX-API-DMAC7.html)
CA (1) CA2400178A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0204555A3 (cg-RX-API-DMAC7.html)
MA (1) MA26883A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02008072A (cg-RX-API-DMAC7.html)
NO (1) NO20023866L (cg-RX-API-DMAC7.html)
NZ (1) NZ520749A (cg-RX-API-DMAC7.html)
PL (1) PL357111A1 (cg-RX-API-DMAC7.html)
TW (1) TWI232756B (cg-RX-API-DMAC7.html)
WO (1) WO2001060325A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200206553B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
MXPA05002065A (es) 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
EP1947938A4 (en) * 2005-11-02 2009-07-01 Cpex Pharmaceuticals Inc MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANE DRUG DELIVERY
EP1959929A4 (en) * 2005-12-14 2012-08-15 Zars Pharma Inc COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
KR20080080355A (ko) * 2005-12-28 2008-09-03 데이코쿠 세이야쿠 가부시키가이샤 손·발톱용 의약 조성물
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
EP2395839B1 (en) * 2009-02-13 2014-05-07 Topica Pharmaceuticals, Inc Anti-fungal formulation
AU2010226476B2 (en) * 2009-03-20 2013-02-07 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE69216446T2 (de) * 1991-03-13 1997-06-26 Firmenich & Cie Verfahren zur Herstellung von 15-Pentadecanolid oder von an diesem Makrolid reichen Gemischen
CA2211004A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
US6224887B1 (en) * 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
EP1257248A4 (en) 2007-10-03
AU4318901A (en) 2001-08-27
KR20030016227A (ko) 2003-02-26
EP1257248B1 (en) 2011-10-05
WO2001060325A1 (en) 2001-08-23
CA2400178A1 (en) 2001-08-23
ZA200206553B (en) 2003-11-17
BR0108438A (pt) 2003-04-01
KR20080049148A (ko) 2008-06-03
NO20023866D0 (no) 2002-08-15
JP2005503318A (ja) 2005-02-03
EP1257248A1 (en) 2002-11-20
PL357111A1 (en) 2004-07-12
AU2001243189B2 (en) 2005-06-09
HUP0204555A2 (en) 2003-05-28
MXPA02008072A (es) 2004-04-05
MA26883A1 (fr) 2004-12-20
NZ520749A (en) 2004-06-25
HUP0204555A3 (en) 2004-06-28
TWI232756B (en) 2005-05-21
ATE526917T1 (de) 2011-10-15
CN1422142A (zh) 2003-06-04

Similar Documents

Publication Publication Date Title
NO20023866L (no) Farmasöytisk preparat
JP2005503318A5 (cg-RX-API-DMAC7.html)
EA200000964A1 (ru) Жидкие полимерные композиции для регулируемого выделения биоактивных веществ
CA2548897A1 (en) Endoparasiticidal agents for topical application
PT1150661E (pt) Produto para pulverizacao para aplicacao topica
CA2492976A1 (en) Solution for ungual and peri-ungual application
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
AU3853395A (en) Preparation of hollow microcapsules
MXPA03005375A (es) Formulacion repelente de insectos que contiene solventes polares, que tiene baja viscosidad y de entrega mediante dispositivo piezoelectrico.
MY101536A (en) Anti-inflammatory and analgesic tape for external use
DE69939180D1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
JPH06211651A (ja) 爪白癬治療用組成物
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
GEP20022628B (en) Nimesulide Gel Systems For Topical Use
WO2001055092A3 (de) 5-aminolävulinsäure-formulierung in nichtwässrigen lösungsmitteln
MXPA04011990A (es) Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
GB1465665A (en) Topical composition
PT831706E (pt) Composicoes aquosas contendo um composto de halogenoalcinilo e um tampao para providenciar actividade biocida e para estabilizar formulacoes para usos finais
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
EP2910254B1 (en) Base and external preparation for skin
JPH02290810A (ja) エアゾール製剤
CA2591307A1 (en) Injectable veterinary composition
DE60119914D1 (de) Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application